07-25 Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
04-19 Instem Limited Announces Termination of Director Appointment, Effective April 20, 2026 CI
04-15 Instem Announces Appointment of Szczepan Baran as Chief Scientific Officer CI
03-19 Instem And U.S. Food And Drug Administration Extend Research Collaboration Agreement CI
12-02 Instem Unveils New Global Headquarters in Boston, Massachusetts CI
25-10-09 Instem Announces Enhanced Capabilities of Climb? Software for Non-GLP In Vivo Research CI
25-07-28 Instem Limited acquired Rockstep Solutions, Inc. CI
25-07-17 Instem Announces Provantis 12: A Powerful Step Forward in Preclinical Study Management CI
25-06-18 Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-05-18 Instem Limited acquired Strong Tower Solutions, Inc. CI
25-01-08 Instem Introduces Cloud-Hosted Non-Glp Pathology Module for Provantis CI
24-12-26 Instem plc acquired Trimetra Limited. CI
24-10-04 Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
24-06-17 Instem and Proscia Partners to Accelerate Preclinical Development with Digital Pathology CI
24-01-25 Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline CI
23-11-21 Instem Delists from London Bourse's AIM After Merger with ArchiMed MT
23-11-20 France's Archimed Completes Acquisition of UK's Instem MT
23-11-20 Instem plc Announces Board Resignations CI
23-11-19 ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers. CI
23-11-16 Instem acquisition by Ichor sanctioned by UK court AN
23-11-16 Instem : Issue of Equity, PDMR Dealings and Rule 2.9 Announcement PU
23-11-16 UK Court Clears Archimed’s Takeover of Instem MT
23-11-15 Samson Rock Capital LLP - Form 8.3 - Instem Plc PR
23-11-13 Samson Rock Capital LLP - Form 8.3 - Instem Plc PR
23-11-10 Samson Rock Capital LLP - Form 8.3 - Instem Plc PR
No results match your criteria